PART III: FIBRILLAR Aβ CHAPTER 6: FIBRILLAR Aβ25-35 PRE-TREATMENT WITH SPRC REDUCED DAMAGE INDUCED BY Aβ25-35 FIBRILS 6.1 Results 6.1.1 Effects of incubation time on cell viability Cell viability (% control) 1.2 * * 0.8 ** ** 0.6 0.4 Without Aβ µM 0.2 With Aβ µM 16 24 Time of incubation/h Figure 42: Effects of different times of incubation with aggregated Aβ25-35 on cell viability, expressed as percentage of cell viability compared to the untreated control ± S.E.M N= 3, *: p